コンテンツへスキップ
Merck

Consequences of misdiagnosis and mismanagement of Takotsubo cardiomyopathy.

Acute cardiac care (2012-12-12)
Chirayu Vyas, Sanjay Shah, Sameer Pancholy, Tejas Patel, Isam Moussa
要旨

We report a patient who presented with takotsubo cardiomyopathy but was misdiagnosed as an anterior wall ST elevation myocardial infarction (AWMI). We illustrate how misdiagnosis led to mismanagement by initiating intravenous inotropic agents that led to further hemodynamic compromise. Subsequent withdrawal of the inotropic agents and simultaneous administration of oral metoprolol therapy led to hemodynamic and clinical improvement re-affirming the diagnosis of takotsubo cardiomyopathy.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
(±)-メトプロロール (+)-酒石酸塩, ≥98% (titration), powder
Supelco
(±)-メトプロロール (+)-酒石酸塩, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Metoprolol tartrate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
(±)-メトプロロール (+)-酒石酸塩, European Pharmacopoeia (EP) Reference Standard